Universal-Beteiligungs- und Servicegesellschaft’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.24M Sell
88,164
-47,768
-35% -$2.47M 0.01% 847
2026
Q1
$7.01M Buy
135,932
+49,574
+57% +$2.31M 0.01% 740
2025
Q4
$2.7M Buy
86,358
+6,459
+8% +$175K ﹤0.01% 1150
2025
Q3
$2.06M Sell
79,899
-57,182
-42% -$1.6M ﹤0.01% 1282
2025
Q2
$3.78M Sell
137,081
-315,632
-70% -$8.31M 0.01% 941
2025
Q1
$12.8M Buy
452,713
+17,799
+4% +$632K 0.03% 482
2024
Q4
$18.1M Buy
+434,914
New +$20.8M 0.04% 387

Other funds holding MRNA

Universal-Beteiligungs- und Servicegesellschaft's MRNA Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Moderna (MRNA) stake by 35% in Q2 2026, selling an estimated $2.47M and leaving 88,164 shares worth $6.24M. The position accounts for 0.01% of the portfolio, ranked #847.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. The position peaked at $18.1M in Q4 2024. 542 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 88,164 shares of Moderna worth $6.24M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 47,768 Moderna shares in Q2 2026, an estimated $2.47M.
  • Moderna made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #847 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Moderna position peaked at $18.1M in Q4 2024.
  • 542 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.